VICKI MCINTYRE: Open Payments
NPI 1629075643 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,210 in 68 payments from 12 companies in 2025. Trend: 2023 $13,066 · 2024 $15,156 · 2025 $9,210
Speaker / faculty: $4,520Food & beverage: $1,986Consulting: $1,610Travel & lodging: $1,094
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 26 | $7,816 |
| Madrigal Pharmaceuticals | 7 | $323 |
| Aimmune Therapeutics, Inc. | 12 | $303 |
| Alexion Pharmaceuticals, Inc. | 2 | $244 |
| Ipsen Biopharmaceuticals, Inc | 8 | $147 |
| Mallinckrodt Hospital Products Inc. | 1 | $146 |
| Intercept Pharmaceuticals, Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $69 |
| ORPHALAN INC | 2 | $34 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
Products named: Epclusa, REZDIFFRA, ZENPEP, Livdelzi, IQIRVO, TERLIVAZ, OCALIVA, MAVYRET.
Industry payments across AZ — which companies pay providers there.
